Showing results (1871-1880 of 2,138) with videos related to
Sort By:
Pageof 214
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|April 15, 2000
Mutation analysis of 3 genes in patients with Leber congenital amaurosisA J Lotery, P Namperumalsamy, S G Jacobson, et al.Human Molecular Genetics|August 7, 2013
Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt diseaseTerry A Braun, Robert F Mullins, Alex H Wagner, et al.Blood Advances|October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Genotype-immunophenotype relationships in <i>NPM1</i>-mutant AML clonal evolution uncovered by single cell multiomic analysisMorgan Drucker, Darren Lee, Xuan Zhang, et al.Cancer|May 1, 2015
Health care utilization and end-of-life care for older patients with acute myeloid leukemiaAreej R El-Jawahri, Gregory A Abel, David P Steensma, et al.Leukemia|March 22, 2017
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemiaA-K Eisfeld, K Mrózek, J Kohlschmidt, et al.Schizophrenia Bulletin|April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical OutcomeGemma Modinos, Paul Allen, Andre Zugman, et al.Leukemia|February 10, 2019
Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinicallyKrzysztof Mrózek, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.Molecular Psychiatry|June 9, 2018
Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre <sup>1</sup>H-MRS study (OPTiMiSE)A Egerton, B V Broberg, N Van Haren, et al.Pageof 214